首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) study
【24h】

The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) study

机译:预期IQ-CSRC试验:替代ICH E14彻底QTC(TQT)研究的原型早期临床预审性评估调查

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Early clinical Phase I ECG investigations designed to replace the currently applied thorough QT (TQT) study are reviewed to examine how they could complement and verify the conclusions of nonclinical investigations and, in particular, the Comprehensive in vitro Proarrhythmia Assay (CiPA).
机译:简介:审查了旨在取代目前应用的ECG调查的ECG调查,审查了他们如何补充和验证非临床调查的结论,特别是全面的体外预血淋淋的测定(CIPA)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号